Increased fracture risk was particularly dangerous during the first two weeks after therapy, when the relative risk was seven times higher than patients in patients on a short-acting opioid.
After the initial two week period, the fracture risk associated with short-acting opioids dropped off but still remained greater than with NSAID therapy.
Read the Internal Medicine News report on short-acting opioids.
Read more on anesthesia:
–Maryland Anesthesiologist Arrested for Alleged Narcotic Distribution
–FDA Accepts Drug Application for Postsurgical Pain Management
–Blocking Receptor Might Help Control Post-Surgery Pain or Inflammation
